Johnson Matthey has completed an expansion of its Cambridge, UK facilities, bringing additional process research and development services and kilo-scale manufacture to the growing site. This investment supports the use of Johnson Matthey’s catalyst and biocatalyst technology in process R&D and non-GMP production of materials for pre-clinical pharmaceutical and toxicology studies. The expansion will accommodate teams of chemistry and biocatalysis process R&D scientists who will provide...